CytoTools AG
XETRA:T5O

Watchlist Manager

CytoTools AG

XETRA:T5O

Watchlist

Dividends

Discount Rate

Price: 101.26 EUR 0.98%

Market Cap: 52.8m EUR

Have any thoughts about
CytoTools AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 101.26 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

T5O Alert

CytoTools AG

101.26

-901.54 (-89.9%)

52 Week Range	N/A N/A
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CytoTools AG

What unique competitive advantages
does CytoTools AG hold over its rivals?

What risks and challenges
does CytoTools AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CytoTools AG.

What unique competitive advantages
does CytoTools AG hold over its rivals?

What risks and challenges
does CytoTools AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CytoTools AG.

Provide P/S
for CytoTools AG.

Provide P/E
for CytoTools AG.

Provide P/OCF
for CytoTools AG.

Provide P/FCFE
for CytoTools AG.

Provide P/B
for CytoTools AG.

Provide EV/S
for CytoTools AG.

Provide EV/GP
for CytoTools AG.

Provide EV/EBITDA
for CytoTools AG.

Provide EV/EBIT
for CytoTools AG.

Provide EV/OCF
for CytoTools AG.

Provide EV/FCFF
for CytoTools AG.

Provide EV/IC
for CytoTools AG.

Show me price targets
for CytoTools AG made by professional analysts.

What are the Revenue projections
for CytoTools AG?

How accurate were the past Revenue estimates
for CytoTools AG?

What are the Net Income projections
for CytoTools AG?

How accurate were the past Net Income estimates
for CytoTools AG?

What are the EPS projections
for CytoTools AG?

How accurate were the past EPS estimates
for CytoTools AG?

What are the EBIT projections
for CytoTools AG?

How accurate were the past EBIT estimates
for CytoTools AG?

Compare the revenue forecasts
for CytoTools AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CytoTools AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CytoTools AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of CytoTools AG compared to its peers.

Compare the P/E ratios
of CytoTools AG against its peers.

Discuss the investment returns and shareholder value creation
comparing CytoTools AG with its peers.

Analyze the financial leverage
of CytoTools AG compared to its main competitors.

Show all profitability ratios
for CytoTools AG.

Provide ROE
for CytoTools AG.

Provide ROA
for CytoTools AG.

Provide ROIC
for CytoTools AG.

Provide ROCE
for CytoTools AG.

Provide Gross Margin
for CytoTools AG.

Provide Operating Margin
for CytoTools AG.

Provide Net Margin
for CytoTools AG.

Provide FCF Margin
for CytoTools AG.

Show all solvency ratios
for CytoTools AG.

Provide D/E Ratio
for CytoTools AG.

Provide D/A Ratio
for CytoTools AG.

Provide Interest Coverage Ratio
for CytoTools AG.

Provide Altman Z-Score Ratio
for CytoTools AG.

Provide Quick Ratio
for CytoTools AG.

Provide Current Ratio
for CytoTools AG.

Provide Cash Ratio
for CytoTools AG.

What is the historical Revenue growth
over the last 5 years for CytoTools AG?

What is the historical Net Income growth
over the last 5 years for CytoTools AG?

What is the current Free Cash Flow
of CytoTools AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for CytoTools AG.

T5O

Income Statement

Income from Continuing Operations

CytoTools AG
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

CytoTools AG
Income from Continuing Operations Peer Comparison

Comparables:

BNTX

MOR

IMTX

BIO

FYB

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	CytoTools AG XETRA:T5O	Income from Continuing Operations -€660.7k	CAGR 3-Years 22%	CAGR 5-Years 9%	CAGR 10-Years 2%
	BioNTech SE NASDAQ:BNTX	Income from Continuing Operations €930.3m	CAGR 3-Years 296%	CAGR 5-Years N/A	CAGR 10-Years N/A
	MorphoSys AG XETRA:MOR	Income from Continuing Operations -€456.3m	CAGR 3-Years -37%	CAGR 5-Years -50%	CAGR 10-Years N/A
	Immatics NV NASDAQ:IMTX	Income from Continuing Operations -€97m	CAGR 3-Years 23%	CAGR 5-Years -25%	CAGR 10-Years N/A
	Biotest AG XETRA:BIO	Income from Continuing Operations €192.2m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 20%
	Formycon AG XETRA:FYB	Income from Continuing Operations €75.8m	CAGR 3-Years N/A	CAGR 5-Years 61%	CAGR 10-Years N/A

What is CytoTools AG's Income from Continuing Operations?

Income from Continuing Operations
-660.7k EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Income from Continuing Operations amounts to -660.7k EUR.

What is CytoTools AG's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
2%

Over the last year, the Income from Continuing Operations growth was 88%. The average annual Income from Continuing Operations growth rates for CytoTools AG have been 22% over the past three years , 9% over the past five years , and 2% over the past ten years .

CytoTools AG
XETRA:T5O

CytoTools AG
Income from Continuing Operations

CytoTools AG
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is CytoTools AG's Income from Continuing Operations?

Income from Continuing Operations
-660.7k EUR

What is CytoTools AG's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
2%

Company

Help

Tools

Stocks

CytoTools AG XETRA:T5O

CytoTools AG Income from Continuing Operations

CytoTools AG Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is CytoTools AG's Income from Continuing Operations? Income from Continuing Operations -660.7k EUR

What is CytoTools AG's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 10Y 2%

Company

Help

Tools

Stocks

CytoTools AG
XETRA:T5O

CytoTools AG
Income from Continuing Operations

CytoTools AG
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is CytoTools AG's Income from Continuing Operations?

Income from Continuing Operations
-660.7k EUR

What is CytoTools AG's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
2%